
Ceftazidime Pentahydrate
CAS No. 78439-06-2
Ceftazidime Pentahydrate( —— )
Catalog No. M21401 CAS No. 78439-06-2
Ceftazidime is a β-lactam antibacterial agent which has demonstrated a broad spectrum of activity against Gram-positive and Gram-negative aerobic bacteria.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCeftazidime Pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCeftazidime is a β-lactam antibacterial agent which has demonstrated a broad spectrum of activity against Gram-positive and Gram-negative aerobic bacteria.
-
DescriptionCeftazidime is a β-lactam antibacterial agent which has demonstrated a broad spectrum of activity against Gram-positive and Gram-negative aerobic bacteria.
-
In VitroCeftazidime (0-8 μg/mL approximately, 24 h) pentahydrate displays antibacterial and anti-biofilm activities against P. aeruginosa strains.Ceftazidime (0-40 μg/mL approximately, 18-20 h) pentahydrate has inhibitory activities against S. maltophilia isolates. Cell Viability Assay Cell Line:P. aeruginosa strains (PAO1, PA1, PA2)Concentration:0-8 μg/mL approximatelyIncubation Time:24 h Result:Displayed antibacterial and anti-biofilm activities with MIC values of 2-4 μg/mL.
-
In VivoCeftazidime (2 h infusion of injection, 2 000 mg, every 8 h for 24 h) pentahydrate moderately reduces bacterial density in a murine thigh infection model. Animal Model:Murine thigh infection modelDosage:2000 mg Administration:2 h infusion of injection, every 8 h for 24 h.Result:Reduced bacterial density against the isogenic NDM (New Delhi metallo-β-lactamase) strain.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number78439-06-2
-
Formula Weight636.7
-
Molecular FormulaC22H32N6O12S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (157.07 mM)
-
SMILESCC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].O.O.O.O.O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richards DM et al. Ceftazidime. A review of its antibacterial activity pharmacokinetic properties and therapeutic use. Drugs. 1985 Feb;29(2):105-61.
molnova catalog



related products
-
(3R,4R)-A2-32-01
(3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.
-
CB-618 sodium salt
CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.
-
Zidebactam
Zidebactam is an effective β-lactamase inhibitor.